持田製薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2017/04/27 | 8,310 | 8,370 | 8,250 | 8,320 | +30 | +0.4% | 49,500 |
| 2017/04/26 | 8,380 | 8,380 | 8,240 | 8,290 | -20 | -0.2% | 29,500 |
| 2017/04/25 | 8,370 | 8,430 | 8,260 | 8,310 | -50 | -0.6% | 34,400 |
| 2017/04/24 | 8,350 | 8,390 | 8,300 | 8,360 | +120 | +1.5% | 21,400 |
| 2017/04/21 | 8,160 | 8,240 | 8,120 | 8,240 | +80 | +1% | 26,700 |
| 2017/04/20 | 8,140 | 8,210 | 8,040 | 8,160 | +50 | +0.6% | 30,200 |
| 2017/04/19 | 8,110 | 8,210 | 8,100 | 8,110 | -20 | -0.2% | 30,600 |
| 2017/04/18 | 8,280 | 8,280 | 8,110 | 8,130 | -30 | -0.4% | 16,700 |
| 2017/04/17 | 8,030 | 8,180 | 8,030 | 8,160 | +130 | +1.6% | 16,800 |
| 2017/04/14 | 8,160 | 8,180 | 8,010 | 8,030 | -140 | -1.7% | 20,900 |
| 2017/04/13 | 8,150 | 8,200 | 8,120 | 8,170 | -60 | -0.7% | 24,900 |
| 2017/04/12 | 8,150 | 8,230 | 8,090 | 8,230 | -10 | -0.1% | 31,900 |
| 2017/04/11 | 8,110 | 8,260 | 8,070 | 8,240 | +110 | +1.4% | 27,300 |
| 2017/04/10 | 8,250 | 8,300 | 8,120 | 8,130 | -110 | -1.3% | 32,300 |
| 2017/04/07 | 8,170 | 8,350 | 8,170 | 8,240 | +20 | +0.2% | 38,000 |
| 2017/04/06 | 8,400 | 8,410 | 8,180 | 8,220 | -150 | -1.8% | 19,900 |
| 2017/04/05 | 8,340 | 8,470 | 8,300 | 8,370 | -20 | -0.2% | 30,800 |
| 2017/04/04 | 8,360 | 8,410 | 8,300 | 8,390 | +20 | +0.2% | 29,000 |
| 2017/04/03 | 8,350 | 8,410 | 8,300 | 8,370 | +110 | +1.3% | 24,100 |
| 2017/03/31 | 8,530 | 8,540 | 8,260 | 8,260 | -160 | -1.9% | 42,200 |
| 2017/03/30 | 8,580 | 8,600 | 8,410 | 8,420 | -250 | -2.9% | 22,300 |
| 2017/03/29 | 8,690 | 8,750 | 8,650 | 8,670 | -100 | -1.1% | 21,000 |
| 2017/03/28 | 8,680 | 8,790 | 8,660 | 8,770 | +210 | +2.5% | 31,900 |
| 2017/03/27 | 8,660 | 8,680 | 8,540 | 8,560 | -80 | -0.9% | 30,200 |
| 2017/03/24 | 8,510 | 8,660 | 8,480 | 8,640 | +110 | +1.3% | 24,900 |
| 2017/03/23 | 8,500 | 8,590 | 8,500 | 8,530 | -80 | -0.9% | 17,500 |
| 2017/03/22 | 8,600 | 8,670 | 8,600 | 8,610 | -130 | -1.5% | 19,600 |
| 2017/03/21 | 8,670 | 8,800 | 8,670 | 8,740 | +40 | +0.5% | 20,900 |
| 2017/03/17 | 8,690 | 8,750 | 8,660 | 8,700 | -100 | -1.1% | 28,700 |
| 2017/03/16 | 8,800 | 8,840 | 8,760 | 8,800 | -70 | -0.8% | 23,600 |
| 2017/03/15 | 8,850 | 8,880 | 8,810 | 8,870 | ±0 | ±0% | 21,500 |
| 2017/03/14 | 8,870 | 8,900 | 8,860 | 8,870 | +50 | +0.6% | 21,800 |
| 2017/03/13 | 8,770 | 8,870 | 8,750 | 8,820 | +80 | +0.9% | 20,600 |
| 2017/03/10 | 8,690 | 8,770 | 8,640 | 8,740 | +190 | +2.2% | 29,400 |
| 2017/03/09 | 8,590 | 8,620 | 8,530 | 8,550 | -30 | -0.3% | 17,900 |
| 2017/03/08 | 8,700 | 8,700 | 8,560 | 8,580 | -30 | -0.3% | 20,600 |
| 2017/03/07 | 8,660 | 8,660 | 8,580 | 8,610 | +30 | +0.3% | 10,100 |
| 2017/03/06 | 8,660 | 8,720 | 8,580 | 8,580 | -120 | -1.4% | 22,800 |
| 2017/03/03 | 8,700 | 8,750 | 8,660 | 8,700 | ±0 | ±0% | 19,500 |
| 2017/03/02 | 8,770 | 8,770 | 8,660 | 8,700 | +60 | +0.7% | 15,100 |
| 2017/03/01 | 8,530 | 8,650 | 8,490 | 8,640 | +170 | +2% | 29,600 |
| 2017/02/28 | 8,510 | 8,570 | 8,470 | 8,470 | -20 | -0.2% | 22,400 |
| 2017/02/27 | 8,490 | 8,500 | 8,370 | 8,490 | ±0 | ±0% | 19,500 |
| 2017/02/24 | 8,500 | 8,530 | 8,420 | 8,490 | +20 | +0.2% | 23,000 |
| 2017/02/23 | 8,450 | 8,490 | 8,410 | 8,470 | +60 | +0.7% | 14,900 |
| 2017/02/22 | 8,410 | 8,430 | 8,360 | 8,410 | ±0 | ±0% | 13,700 |
| 2017/02/21 | 8,350 | 8,460 | 8,350 | 8,410 | -20 | -0.2% | 16,900 |
| 2017/02/20 | 8,300 | 8,450 | 8,290 | 8,430 | +20 | +0.2% | 17,700 |
| 2017/02/17 | 8,360 | 8,430 | 8,300 | 8,410 | ±0 | ±0% | 19,600 |
| 2017/02/16 | 8,400 | 8,460 | 8,390 | 8,410 | +30 | +0.4% | 17,700 |
1851～
1900
件表示中 / 3586件
類似銘柄と比較する
現在ご覧いただいている「持田薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 持田薬 | 331,500円 | +3.0% | +27.5% | 2.41% | 20.99倍 | 0.91倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
| ジーエヌアイ | 281,400円 | +52.1% | +23.3% | 0.00% | 19.98倍 | 3.83倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
| 鳥居薬 | 476,000円 | +12.0% | +28.1% | 2.52% | 26.24倍 | 1.11倍 |
|
ＪＴ傘下。柱の抗ＨＩＶ薬販売権喪失後、自社製品の腎・透析、アレルゲン等の開発強化 |
| ゼリア新薬 | 224,400円 | +13.6% | +29.2% | 2.05% | 11.64倍 | 1.12倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
| ネクセラファーマ | 113,200円 | +197.7% | - | 0.00% | 46.26倍 | 1.48倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
市場注目の銘柄
チャート関連のコラム
